Literature DB >> 19870537

STUDIES ON NATURAL IMMUNITY TO PNEUMOCOCCUS TYPE III : III. CORRELATION OF THE BEHAVIOR IN VIVO OF PNEUMOCOCCI TYPE III VARYING IN THEIR VIRULENCE FOR RABBITS WITH CERTAIN DIFFERENCES OBSERVED IN VITRO.

J F Enders1, M F Shaffer, C J Wu.   

Abstract

AMONG THE EXPERIMENTAL FINDINGS REPORTED IN THIS PAPER TO WHICH WE WISH TO GIVE PARTICULAR EMPHASIS ARE THE FOLLOWING: 1. The results which follow the intravenous injection into rabbits of two strains of Pneumococcus Type III of different degrees of virulence vary with the state of the capsule. Thus when this structure is completely developed both remain in the blood. A culture of either strain begins to become susceptible to the blood-clearing mechanism contemporaneously with the onset of capsular degeneration and the initiation of other concomitant changes at the surface of the organism (cf Paper II), which occur much earlier with the less virulent strain. 2. When, in either case, removal from the blood stream occurs, this is effected by the phagocytic cells of the body. There is no suggestion that a new or unknown mechanism is involved. The greatest share of the burden is borne by the fixed phagocytic cells of the liver and spleen, and to a less extent by those of the lung and bone marrow. Nevertheless, it has been demonstrated that the polymorphonuclear leucocytes may also participate. 3. Phagocytosis by the leucocytes of the normal animal either in intro or in vivo has been observed only at such a time as the capsule has become impaired. Ingestion of the organisms by the fixed tissue cells appears also to be effective only under the same condition and is accordingly observed with much younger cultures of the less virulent strain. 4. Following their removal from the blood and their accumulation within the fixed phagocytes of the organs, destruction of most of the cocci proceeds within 2 to 4 hours. Both strains are destroyed provided they are in the state favorable to phagocytic attack. 5. Evidence has been presented which indicates that just as in vitro, so in a local area of inflammation within the body, aging with attendant capsular loss and increasing susceptibility to phagocytosis may take place. 6. With organisms from either strain a variable period of lag follows their injection into the blood stream, even when they are introduced in a state of active multiplication and complete encapsulation. 7. Differences in virulence for rabbits of two strains of Pneumococcus Type III do not imply that this animal possesses a defensive mechanism which is absent in other species, since it has been possible to demonstrate similar differences when the organisms are injected intravenously into mice. This fact indicates that the factors determining the degree of virulence of these strains are to be sought in the organisms themselves, rather than in the kind of host.

Entities:  

Year:  1936        PMID: 19870537      PMCID: PMC2180307          DOI: 10.1084/jem.64.2.307

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : II. THE INFECTIVITY OF TYPE III PNEUMOCOCCUS FOR RABBITS.

Authors:  W S Tillett
Journal:  J Exp Med       Date:  1927-05-31       Impact factor: 14.307

2.  THE PROTECTIVE ACTION OF TYPE I ANTIPNEUMOCOCCUS SERUM IN MICE : II. THE COURSE OF THE INFECTIOUS PROCESS.

Authors:  K Goodner; D K Miller
Journal:  J Exp Med       Date:  1935-08-31       Impact factor: 14.307

3.  STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : II. A METHOD FOR DEMONSTRATING THE GROWTH-INHIBITORY AND BACTERICIDAL ACTION OF NORMAL SERUM-LEUCOCYTE MIXTURES.

Authors:  O H Robertson; R H Sia
Journal:  J Exp Med       Date:  1924-01-31       Impact factor: 14.307

4.  AN IMMUNOLOGICAL STUDY OF THE A SUBSTANCE OR ACETYL POLYSACCHARIDE OF PNEUMOCOCCUS TYPE I.

Authors:  J F Enders; C J Wu
Journal:  J Exp Med       Date:  1934-07-31       Impact factor: 14.307

  4 in total
  8 in total

1.  The inhibition of surface phagocytosis by the capsular slime layer of pneumococcus type III.

Authors:  W B WOOD; M R SMITH
Journal:  J Exp Med       Date:  1949-07       Impact factor: 14.307

2.  A rabbit model of non-typhoidal Salmonella bacteremia.

Authors:  Aruna Panda; Ivan Tatarov; Billie Jo Masek; Justin Hardick; Annabelle Crusan; Teresa Wakefield; Karen Carroll; Samuel Yang; Yu-Hsiang Hsieh; Michael M Lipsky; Charles G McLeod; Myron M Levine; Richard E Rothman; Charlotte A Gaydos; Louis J DeTolla
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2014-07-03       Impact factor: 2.268

3.  The significance of fever in infections.

Authors:  I L BENNETT
Journal:  Yale J Biol Med       Date:  1954-06

4.  THE VIRULENCE OF GROUP C HEMOLYTIC STREPTOCOCCI OF ANIMAL ORIGIN.

Authors:  C V Seastone
Journal:  J Exp Med       Date:  1939-09-30       Impact factor: 14.307

5.  THE DISTRIBUTION IN THE BLOOD AND LYMPH OF PNEUMOCOCCUS TYPE III INJECTED INTRAVENOUSLY IN RABBITS, AND THE EFFECT OF TREATMENT WITH SPECIFIC ANTISERUM ON THE INFECTION OF THE LYMPH.

Authors:  M E Field; M F Shaffer; J F Enders; C K Drinker
Journal:  J Exp Med       Date:  1937-03-31       Impact factor: 14.307

6.  Warming up for a better fever: a randomized pilot study in pediatric oncology.

Authors:  Hanno S Krafft; Christa K Raak; Ekkehart Jenetzky; Tycho J Zuzak; Alfred Längler; David D Martin
Journal:  Pilot Feasibility Stud       Date:  2022-08-16

7.  Studies on the cellular immunology of acute bacteremia. I. Intravascular leucocytic reaction and surface phagocytosis.

Authors:  W B WOOD; M R SMITH; W D PERRY; J W BERRY
Journal:  J Exp Med       Date:  1951-12-01       Impact factor: 14.307

8.  THE PASSAGE OF TYPE III RABBIT VIRULENT PNEUMOCOCCI FROM THE VASCULAR SYSTEM INTO JOINTS AND CERTAIN OTHER BODY CAVITIES.

Authors:  M F Shaffer; G A Bennett
Journal:  J Exp Med       Date:  1939-08-31       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.